Inventor
NAEF RETO
CH16 patents
⚠️ This page may combine multiple inventors who share the name “NAEF RETO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TOPADUR PHARMA AG
7 patentsUS12351585B2Jul 8, 2025
2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
TOPADUR PHARMA AG0 citations60
US11905293B2Feb 20, 2024
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof
TOPADUR PHARMA AG0 citations60
US11897890B2Feb 13, 2024
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
TOPADUR PHARMA AG0 citations60
US11242347B2Feb 8, 2022
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
TOPADUR PHARMA AG0 citations60
US11155558B2Oct 26, 2021
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof
TOPADUR PHARMA AG0 citations60
US10570137B2Feb 25, 2020
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
TOPADUR PHARMA AG0 citations49
US12502393B2Dec 23, 2025
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof
TOPADUR PHARMA AG0 citations38
SANDOZ LTD
3 patentsUS5177085AJan 5, 1993
Dihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthma
SANDOZ LTD81 citations95
US4980359ADec 25, 1990
Isoquinoline derivatives and their use
SANDOZ LTD28 citations90
US5643870AJul 1, 1997
O-acylated cyclosporins
SANDOZ LTD57 citations88